MCGRATH RENTCORP·4

Feb 25, 7:35 PM ET

Lieffrig John 4

4 · MCGRATH RENTCORP · Filed Feb 25, 2026

Insider Transaction Report

Form 4
Period: 2026-02-23
Lieffrig John
VP and Division Manager
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-23+80023,241 total
  • Tax Payment

    Common Stock

    2026-02-23$113.07/sh421$47,60222,820 total
  • Exercise/Conversion

    Common Stock

    2026-02-24+41723,237 total
  • Exercise/Conversion

    Common Stock

    [F4]
    2026-02-24+1,99025,227 total
  • Tax Payment

    Common Stock

    2026-02-24$114.48/sh706$80,82324,521 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1]
    2026-02-23800801 total
    Exercise: $0.00Exp: 2031-02-23Common Stock (800 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1]
    2026-02-244170 total
    Exercise: $0.00Exp: 2030-02-24Common Stock (417 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F2][F3]
    2026-02-241,2500 total
    Exercise: $0.00Exp: 2030-02-24Common Stock (1,250 underlying)
Footnotes (4)
  • [F1]The restricted stock unit shall vest 33% on the first annual anniversary of the grant; 33% on the second annual anniversary of the grant; and 34% on the third annual anniversary of the grant. Each restricted stock unit represents a right to receive one share of common stock or an amount equal to the fair market value of the common stock underlying the unit on the vesting date.
  • [F2]The RSUs are subject to a performance based vesting component at the end of a three-year performance period.
  • [F3]The conversion price of the RSUs was based on the closing price of McGrath RentCorp common stock on February 24, 2026 and therefore such date is determined to be the date exercisable.
  • [F4]Shares acquired upon vesting of performance based RSUs. Each vested RSU converts into 159.21% of one share of McGrath RentCorp common stock.
Signature
Gilda Malek, POA for John Lieffrig|2026-02-25

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT